Nutra Pharma Corp. (NPC) :: NPC Blog http://www.nutrapharma.com/blog The corporate blog of Nutra Pharma Corporation Wed, 02 May 2012 14:03:52 +0000 en hourly 1 http://wordpress.org/?v=3.1 Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin™ http://www.nutrapharma.com/blog/2012/05/02/nutra-pharma-begins-affiliate-sales-marketing-program-for-the-distribution-of-nyloxin%e2%84%a2/ http://www.nutrapharma.com/blog/2012/05/02/nutra-pharma-begins-affiliate-sales-marketing-program-for-the-distribution-of-nyloxin%e2%84%a2/#comments Wed, 02 May 2012 12:54:41 +0000 Rik Deitsch http://www.nutrapharma.com/blog/?p=992 Nutra Pharma announces the roll-out of a two-level, on-line affiliate sales and marketing plan for the sales and distribution of their Nyloxin™ line of pain relievers.

May 2, 2012 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that LWR Partners, their outside branding and marketing firm, has begun their on-line affiliate sales and marketing program to aid in the promotion, branding and distribution of Nyloxin™. Click here to read more.

]]> http://www.nutrapharma.com/blog/2012/05/02/nutra-pharma-begins-affiliate-sales-marketing-program-for-the-distribution-of-nyloxin%e2%84%a2/feed/ 0 Nutra Pharma Letter to Shareholders http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/ http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/#comments Tue, 20 Dec 2011 14:55:23 +0000 Rik J. Deitsch http://www.nutrapharma.com/blog/?p=987 Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company.

December 19, 2011 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the Company’s Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company’s website.

“We have been very busy here at Nutra Pharma,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “I wanted to take this opportunity to outline the progress that we’ve made and the timeline for our future efforts moving into 2012 and beyond,” he concluded.

Nutra Pharma currently produces three drugs for the treatment of pain: Cobroxin®, an over-the-counter pain reliever designed to treat moderate to severe (Stage 2) chronic pain; as well as Nyloxin™ and Nyloxin™ Extra Strength, stronger versions of Cobroxin®. These products are currently available in the United States as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress.

Click here to download the letter

]]> http://www.nutrapharma.com/blog/2011/12/20/nutra-pharma-letter-to-shareholders/feed/ 0 Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/ http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/#comments Wed, 30 Nov 2011 14:31:48 +0000 Corporate Communications http://www.nutrapharma.com/blog/?p=980 Nutra Pharma announces the publication of their study outlining the mechanism of action of their pain drugs to be published in the journal Neuropharmacology.

November 30, 2011 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain. Read on…

]]> http://www.nutrapharma.com/blog/2011/11/30/nutra-pharma-announces-publication-of-a-new-mechanism-study-of-alpha-cobratoxin-in-the-treatment-of-pain/feed/ 0 Incredible Offer on Cobroxin! http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/ http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/#comments Thu, 17 Nov 2011 19:41:15 +0000 Corporate Communications http://www.nutrapharma.com/blog/?p=954 SAVE!

on the first over-the-counter pain reliever clinically proven to treat various levels of chronic pain.

Specially formulated for arthritis, lower back pain, shoulder pain,migraines, and neuralgia.

Now Only $10.99

Regular Price $25.99
And, when you purchase the Cobroxin Gel, you will get the Oral Spray for free, that’s a total savings of $21.00!

Just use Coupon Code: NP11 at checkout

Plus, take advantage of Free Ground Shipping (in the USA) until December 31, 2011.

BUY NOW

 

]]> http://www.nutrapharma.com/blog/2011/11/17/incredible-offer-on-cobroxin/feed/ 0